NOVEL TECHNOLOGIES FOR NONINVASIVE DETECTION, DIAGNOSIS AND TREATMENT OF CANCER
Release Date: December 10, 2001
NOTICE: NOT-CA-02-004
National Cancer Institute
The Unconventional Innovations Program (UIP) of the National Cancer
Institute (NCI) is seeking revolutionary technologies for cancer
research. The UIP is soliciting proposals for the development of
multifunctional technology platforms to support minimally intrusive
approaches that integrate: a) sensing of the fundamental signatures of
precancers, or early, metastatic, or recurring cancers in the living
body, b) transmission of signature information to an external monitor,
c) controlled, specific, treatment, d) monitoring of the effects of
treatment. The UIP particularly seeks technology platforms that
integrate novel approaches to signature recognition, signal generation,
signal amplification, signal transmission, intervention delivery,
intervention feedback, and data interpretation. Proposals are
encouraged from investigators from a variety of disciplines including,
but not limited to, biomedical research, chemistry, physics,
engineering, and computational sciences, particularly as
multidisciplinary teams. The detailed Broad Agency Announcement (RFP:
N01-CO-27031-16) is available on the web site of the Research Contracts
and Acquisition Branch, NCI at:
http://rcb.nci.nih.gov/appl/rfp/published_rfps.jsp with instructions
for submission of proposals and evaluation criteria.
INQUIRIES
For further information, contact:
Annmarie L. Keane
Contract Specialist
Treatment, Biology, and Sciences Section, RCB
Executive Plaza South
6120 Executive Blvd.
Rockville, MD 20892-7220
e-mail: [email protected]
voice: 301-496-8620
fax: 301-402-6699
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
| ||||||
Department of Health and Human Services (HHS) |
||||||
NIH... Turning Discovery Into Health® |